Stocks · Korea
006620
KOSDAQ
DongKoo Bio & Pharma
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER1.94x
PBR0.64x
EPS1,859 KRW
BPS5,610 KRW
ROE33.86%
Dividend yield3.33%
DPS120 KRW
Payout ratio6.46%
Returns and 52-week range
1W+3.71%
1M+3.56%
3M-3.84%
6M-31.16%
1Y-27.73%
YTD-31.80%
52W high6,300원
52W low3,315원
From 52W high-42.30%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1,950억 | 170억 | 66억 | 8.7% |
| 2023 | 2,157억 | 146억 | 118억 | 6.8% |
| 2024 | 2,493억 | 127억 | 20억 | 5.1% |
| 2025 | 2,427억 | 92억 | 502억 | 3.8% |
| Quarterly | ||||
| 2024 4Q | 576억 | -5억 | -82억 | -0.8% |
| 2025 1Q | 587억 | 23억 | -7억 | 4.0% |
| 2025 2Q | 601억 | 19억 | 113억 | 3.2% |
| 2025 3Q | 620억 | 22억 | -16억 | 3.5% |
| 2025 4Q | 619억 | 28억 | 412억 | 4.5% |
| 2026 1Q | 581억 | 18억 | -6억 | 3.1% |
Company
Address: 서울특별시 송파구 법원로 114, B동 14층
Peers in the same sector
Recent filings
- 2026-09-10[기재정정]주요사항보고서(영업정지) Major
- 2026-08-18[기재정정]주요사항보고서(영업정지) Major
- 2026-08-18[기재정정]주요사항보고서(영업정지) Major
- 2026-08-12반기보고서 (2026.06)
- 2026-07-22주요사항보고서(자기주식취득신탁계약체결결정) Major
- 2026-06-25[기재정정]사업보고서 (2025.12)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.